Developing Yeast Models of Human Neurodegenerative Disorders
Neurodegenerative diseases represent one of the most devastating types of diseases in older populations in our time. Significant efforts have been made over the last 20 years to understand the molecular, biochemical, and physiological alterations underlying these diseases. However, in most cases, little is known about their pathological mechanisms due to their high complexity and involvement of a multiplicity of cellular pathways. To gain insight into this group of disorders and to devise potential therapeutic approaches, cellular and animal models of neurodegenerative proteinopathies have been created. Among them, the yeast Saccharomyces cerevisiae has been one of the most popular model organisms due to the degree of conservation of many biological pathways from yeast to human as well as its ease of use. Here, we describe how to create yeast models of neurodegenerative proteinopathies by ectopic expression of human proteins and how to perform a basic characterization of these models by analyzing cellular toxicity and protein aggregation.
- Phage Display Technology for Identifying Specific Antigens on Brain Endothelial Cells
- Ca2+ Recordings: Hardware and Software (From Microscopes to Cameras)
- Detection of Neuropeptides by Immunocytochemistry
- A Neuron-Astrocyte Co-Culture System to Investigate Astrocyte-Secreted Factors in Mouse Neuronal Development
- Monitoring Caspases in Neuronal Cell Death
- Examining Cerebral Angiogenesis in Response to Physical Exercise
- In Vivo and In Vitro Studies on Peptide Release
- Alcohol Tolerance: Methodological and Experimental Issues
- Isolation and Properties of Endothelial Cells Forming the Blood-Nerve Barrier
- Electron Microscopic Assessment